今日解读！苹果发布“苹果智能”：Siri升级接入ChatGPT，AI能力全面增强

苹果发布“苹果智能”：Siri升级接入ChatGPT，AI能力全面增强

北京时间2024年6月11日讯，在备受瞩目的苹果全球开发者大会（WWDC 2024）上，苹果公司发布了全新的人工智能战略，并推出了名为“苹果智能”的整合方案。该方案将把人工智能技术应用于包括Siri语音助手在内的一系列苹果产品和服务中，并与OpenAI合作，将强大的人工智能语言模型ChatGPT引入苹果设备。

此次发布标志着苹果人工智能战略的重大升级。通过将ChatGPT整合到Siri中，苹果将显著提升Siri的自然语言处理能力，使其能够更好地理解用户的意图，并提供更加智能化的响应和服务。

具体而言，升级后的Siri将拥有以下新功能：

• 更丰富的语言理解能力：即使用户表达不清楚，Siri也能理解意思；它可以在对话时联系上下文，比如知道用户说的“那里”是之前提到的一个地方。
• 支持用户切换语音和文字交互方式：当不想出声时，用户可以打字给Siri，让它实现定闹钟等功能，选择适合场景的交互方式。
• 掌握了大量关于功能和设置的信息：当用户想知道如何在iPhone、iPad或Mac上做某事时，即使不知道某个功能的确切名称，用户也可以简单地描述它，Siri能明白用户所说的功能是什么。

此外，“苹果智能”还将为Siri提供屏幕感知能力，支持其针对屏幕信息采取行动。例如，一个朋友从消息中发短信写到新地址，用户可以让Siri把这个地址添加到他的联系人卡片上。

苹果表示，公司将继续投入研发，进一步提升“苹果智能”的能力，并将人工智能技术应用于更多产品和服务中，为用户提供更加智能化的体验。

专家分析：

“苹果智能”的发布是苹果人工智能战略的重要一步，标志着苹果在人工智能领域进入了一个新阶段。通过将ChatGPT整合到Siri中，苹果将显著提升Siri的智能化水平，使其能够为用户提供更加个性化和便捷的服务。这将有利于苹果进一步巩固其在智能手机市场的地位，并推动人工智能技术的普及应用。

以下是本次新闻稿的几点补充：

• 苹果并未透露ChatGPT的接入是否会对用户产生额外费用。
• 一些业内人士认为，ChatGPT的接入可能会对其他第三方语音助手造成冲击。
• 也有专家指出，人工智能技术的发展也带来了一些潜在的风险，例如隐私泄露和伦理问题，需要得到重视。

以下是新标题的建议：

• Siri迎来重大升级！苹果发布“苹果智能”，内置ChatGPT可免费使用
• 苹果人工智能战略升级：Siri接入ChatGPT，AI能力全面增强
• 苹果WWDC 2024发布“苹果智能”：人工智能新时代开启

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.